Signing an OEM contract without reading the fine print is one of the most expensive mistakes a beauty brand can make. Whether you are placing your first private-label order or scaling to a six-figure run, the contract between you and your cosmetics manufacturer defines who owns the formula, what happens if a batch fails, and whether you are locked in to a single supplier for years. This guide walks through three real-world contract examples — the types of clauses you will encounter, what each one means in practice, and the specific terms you should negotiate before you sign.

Key Takeaways

  • OEM cosmetics contracts cover far more than price and quantity — IP ownership, exclusivity, and liability clauses can make or break your brand’s future flexibility.
  • A basic product development agreement is often the first document you sign; treat it as seriously as the manufacturing agreement that follows.
  • Always negotiate MOQ, lead time, and payment milestones in writing before sampling begins — verbal assurances are unenforceable.

Example 1: The Basic Product Development Agreement

The product development agreement (PDA) — sometimes called a development service agreement or formulation brief acknowledgment — is typically signed when you first engage a manufacturer to develop a custom formula or adapt a stock formula to your specification. At this stage, money changes hands before any finished goods exist, so this document carries real financial risk.

What a typical PDA covers:

  • Development fees: A non-refundable fee (commonly USD 300–1,500 per SKU) covering lab work, raw material sourcing, and sample rounds. Confirm whether this fee is credited against your first production order.
  • Sample rounds: Most PDAs specify two or three rounds of samples at no additional cost. Beyond that, each round is billed. Negotiate at least three rounds in writing — complex formulas (serums, sunscreens, colour cosmetics) often need more iterations than a manufacturer’s default terms assume.
  • Formula ownership (draft stage): Watch for clauses that say the factory retains ownership of any formula developed during the PDA phase until the first production payment is received in full. This is common and generally fair — but make sure ownership transfers completely on that payment, not on a percentage trigger.
  • Confidentiality: The PDA should include a mutual NDA. If the manufacturer’s template has only a one-way NDA (you protect their information but they are not bound), ask for mutual protection covering your concept, branding direction, and target formulation.

What to watch for: Some manufacturers include a clause granting them the right to offer the same stock formula to other clients if you do not proceed to production within a set period (often 90 days). This is standard for stock formulas but should not apply to custom-developed formulas where you paid a development fee. Negotiate a 12-month exclusivity window on any formula you funded.

Example 2: IP and Formula Ownership Clauses in a Full Manufacturing Agreement

Once sampling is approved, you move to the main manufacturing agreement (MA) — also called a contract manufacturing agreement or supply agreement. This is the binding document that governs ongoing production runs, and it is where IP and formula ownership clauses become critical.

Three IP scenarios you will encounter:

Scenario A — Stock formula, private label: You are purchasing a manufacturer’s existing formula, rebadged with your branding. In this case the manufacturer owns the formula and grants you a licence to sell the finished product under your brand. You cannot patent the formula or prevent the manufacturer from selling the same base to competitors. Acceptable for entry-level brands; problematic once you build brand equity on a formula you do not own.

Scenario B — Custom formula, shared costs: You paid a development fee and co-developed the formula with the manufacturer’s lab team. Contract language varies widely here. Some agreements assign full IP to you on receipt of the development fee; others claim joint ownership. Joint ownership clauses are rarely in your interest — they mean the manufacturer can license your formula to third parties without your consent. Push for a clean assignment of formula IP to you, with the factory retaining only the right to manufacture under your purchase orders.

Scenario C — Fully commissioned formula: You supplied the full brief, formulation data, or existing formula for the manufacturer to replicate. In this case you should already own the IP, but confirm that the MA does not include any sweeping “work-made-for-hire” language that transfers ownership back to the factory. Such clauses occasionally appear in templated contracts from manufacturers who serve markets where local law defaults to factory ownership of manufacturing-related IP.

Additional clauses to negotiate:

  • Right to audit: Request the right to inspect production records and raw material certificates of analysis (CoA) at least once per year with reasonable notice.
  • Exclusivity scope: Define exclusivity narrowly — by formula AND by product category AND by geography if possible. Broad exclusivity clauses that prevent the factory from working with any competitor in your entire category are rarely granted and often unenforceable.
  • Formula escrow: For high-value custom formulas, consider requiring the factory to deposit the full formula specification with a mutually agreed third party (or a notarised copy held by your legal counsel), accessible to you if the factory ceases operations.

Example 3: MOQ, Lead Time, and Payment Terms in Practice

The commercial terms section of a manufacturing agreement is where most first-time brand founders focus — and where the most common misunderstandings arise. Here is what these clauses look like in practice, and how to negotiate them.

MOQ clauses: Most OEM factories state a per-SKU minimum order quantity (MOQ) ranging from 500 to 5,000 units depending on product type and packaging complexity. The published MOQ is rarely the true minimum — factories quote higher to protect margin. For a first production run, ask for a “trial order” or “pilot run” MOQ and offer to pay a slightly higher unit price in exchange. Get the approved MOQ in writing in the MA; verbal reductions are common during negotiation but disappear at invoicing.

Lead time clauses: Lead time runs from purchase order (PO) confirmation to goods ready-for-collection (RFC). Standard clauses quote 45–90 days but rarely account for raw material delays, CNY shutdowns, or certification testing. Negotiate a written lead time with a clear start trigger (PO confirmation + deposit receipt) and a modest penalty clause for delays beyond an agreed buffer (e.g., 15 days beyond stated lead time). Penalty clauses are rarely invoked but their presence incentivises the factory to keep your order prioritised.

Payment terms: The most common structure for first-time clients is 30% deposit on PO, 70% balance before shipment. As you build a relationship, you can negotiate 30/70 with the balance payable on delivery against shipping documents, or even 30/70 with a 30-day credit window. Never release 100% payment upfront. For large orders (USD 50,000+), consider using a letter of credit (LC) to protect both parties — ask whether your manufacturer can accept LC payments, as not all factories have LC-capable banking relationships.

Warranty and rejection clauses: The MA should specify the acceptable defect rate (typically <0.5% for cosmetics), the inspection standard (AQL level II is most common), and the process for returning or reprocessing rejected goods. Confirm whether rejection costs (re-inspection, re-packaging, re-testing) are borne by the factory or shared. A silent contract defaults to “buyer bears return freight” in many jurisdictions.

Disclaimer: This article provides general educational guidance on OEM cosmetics contracting. It is not legal advice. Contract terms vary by jurisdiction and manufacturer. Engage a qualified commercial lawyer to review any manufacturing agreement before signing.